Full Archive

What it could look like.

Something different, something creative, something truly innovative. These are the things I have been clamoring for. My wish list so to speak. But as Momma Kliff used to say if no one will give you what you want do it yourself. So here is MY wish list what I would like to see. 1. Get away from conventional pay as you go and go to a lease vs buy model. This model...

Who’s needs are being met?

When you look at all the Omnipod and Dexcom wannabes one might get the impression there is something wrong with the Omnipod or the Dexcom sensor. That there is an unmet need these wannabes provide. That they are solving a problem and are not another solution looking for a problem to solve. The reality is while these wannabes may have some features the others do not the only need they...

Aeschylus

While the insulin pump market may not be a war in the true sense recent developments have proved that the Greek warrior Aeschylus was correct when he said, “In war, truth is the first casualty.” Let’s start right here in my backyard at Tandem. Since February 22, 2024, the day after Tandem released full year and fourth quarter results for 2023 shares are up over 40%. Keep in mind earnings were...

A Manic Meltdown Monday

When it comes to the diabetes toys dealing with IP lawsuits is just standard operating procedure. As a former executive once said your patent attorneys are like nuclear weapons each side has them hoping to never need them. But as we have seen many times IP lawsuits can have serious consequences. Most recently Medtronic backed out of their nearly $800 buyout of EOFlow over IP issues. One thing we never expected...

A Return to Wacky

Before we begin today a huge shout out to Oakland and their stunning bracket busting upset of blue blood Kentucky. Come to think of it March Madness is about the only thing that can match the wacky world of diabetes. A world where anything can and usually does happen even when it makes no sense whatsoever. A world that up until recently was getting just a little dull but thankfully...

What will it take?

Having followed the insulin pump market almost from its beginning we have seen more than our fair share of successes and failures. There is no question that over the years not only have these systems improved dramatically but the newest series of AID systems can be rightfully called game changing technology. Yet even with this great technology insulin pump are under utilized. At the moment the market is controlled by three...

A New Twiist

Yesterday, Sequel Med Tech, LLC received FDA clearance for their twiist™ AID system. The only reason this is noteworthy is the co-founder and Director of Sequel is none other than Dean Kamen. Now if you don’t know who Dean I is strongly suggest you Google him. He’s not just an inventor but a very smart businessperson. So smart in fact that after selling the twiist two or three times and always...